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This examination consists of two sections.
Section A consists of 5O multiple choice questions.
Section B consists of two (2) long questions.
Answer ALL questions.
Answers to sect,ion A must be entered into the scripts
provided,
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Section A
Mark (/t the answers on the opposite spaee corresponding to
a correct or most appropriate answer for each question.
Each question has only one correct or most appropriate
answer or statement.
1. Which of the following is the najor rnechanism of drug
induced renal problens?
Direct toxicity on renal ce}Is.(a)
(b) Drug creating a condition within
patients that lead to deterioration
renal function.
rmmunologic reactions.
Mechanical obstruction.
Acute tubulo-interstitial disease.
Chronic tubulo-interstitial disease.
Glomerulonephritis.
Acute tubular necrosis.
ln
(c)
(d)
2. Which of the folloving is the least common form of drug
induced renal problen?
(a)
(b)
(c)
(d)
412
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3. Which of the
can be taken to
nephropathy?
following is not an
reduce the incidence
appropriate step that
of d.rug-induced
(a) Hydration with chloride anion during
cisplatin therapy.
(b) Urinary acidification to prevent
methotrexate nephropathy.
Sodium chloride repletion to prevent
amphotericin toxicity.
Calcium supplement during
aminoglycoside therapy.
(c)
(d)
4.
TH
Provide an estimate for the
rrho has a serum creatinine
creatinine clearance for ltlr.
of 25o pmol lL ?
(a)
(b)
(d)
(e)
24 nl/min.
34 rnl/min.
44 nl/nin.
54 ml/nin.
'4LS
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5. Which one of the foltowing drugs requires a dose
rnodification in a patient with a creatinine clearance of 15
ml per rninute?
(a) C.lindamycin.
(b) Chloramphenicol.
(c) Erythromycin.
(d) Anpicillin.
6. Whictr of the following drugs prevents creatinine
secretion in the kidney tubules?
(a) Ascorbic acid.
(b) Probenecid.
(c) Cefoxitin.
(d) Penicillin (high dose) .
41,4
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7. Which of
creatinine
not interfere with
(c) Cefoxitin.
(d) Penicillin (high dose).
8. Which of the foLlowing statements about creatinine and
it,s clearance is not true?
(a) The production of creatinine is
dependent on muscle and correlates
with body weight and body size.
fhere is an apparent circadian rhythm
in creatini"ne excretion, uith a
greater amount excreted in the
afternoon.
A morning fasting serum creatinine
concentration drawn during the urine
collection period should be used to
calculate creatinine clearance.
The Jeliffe i-977 equation is more
reliable and accurate than the
Cockcroff-Gault equation in
estinating creatinine clearance.
the following drugs does
measurement?
(a) Assorbic acid.
(b) Probenecid.
(d)
(c)
. ;'f:.. .
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9. Which of the following conditions does not, affect the
predictive performance of equati"ons to est,imate creatinine
clearance?
(a) Patients not on urinary catheter
(if a complete urine collection
cannot be guaranteed).
(b) Use of lean body weight instead of
total body weight.
(c) Unstable renal function.
(d) Medical conditions that interfere
with serum creatinine assayso
10. Which of the following statenents is/are true?
(i) Nephrotic syndrome is characterized by
severe proteinuria, hypoalbuminemia and
pulmonary edema.
(ii) Nephritic syndrome is characterized by
hematuria, hypertension and
hypoalbuminemia.
(iii) Both nephrotic syndrorne and nephritic
syndrome can occur in a patient with SLE.
(iv) Hypertension is not a characteristis of
nephrotic syndrome"
. . .7 /-
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(a) None of the above statement,s is true.
(b) All of the above statements are true.
(c) Only statements (i) and (ii) are true.
(d) Only statements (iii) and (iv) are
true.
11. Which of the following statements is/are true?
(i) Glomerulonephritis, pyelonephritis and
anticoagulant therapy are aII known causes
of hematuria.
(ii) Pyelonephritis and tuberculosis can cause
both hematuria and proteinuria.
(iii) Multiple.myelorna is a known cause of
proteinuria.
(iv) Proteinuria can be benign"
(a) None of the above statements is true.
(b) All of the above statements are true.
{c) Only statements (i) and (ii) are true.
(d) OnIy statements (iii) and (iv) are
true.
/|attruL (
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L2. Which of the following staLenents is/are true?
(i) Glomerulonephritis is the most conmon
cause of nephrotic syndrome.
(ii) The nercurials and penicillanine are known
to cause nephrotic syndrome.
(iii) Prednisolone ls effective in treating
nephrotic syndrome in 808 of patients.
(iv) Cyclophosphanide is only effective in
nephrotic syndrome secondary to SLE.
(a) None of the above statements is true.
(b) A11 of the above statements are true.
(c) OnIy statements (i) and (ii) are'
true.
(d) Only statements (iii) and (iv) are
true.
13. Which of the folLowing statements is/are true?
(i) Anemia is only associated with chronic
418
t 9
renal failure and not acute renal failure.
(ii) Dietary supplements play no role in the
treatment of anemia of renal fai_lure.
(iii) Recombinant erythropoeitin is indicated in
the treatment of anemia of renal failure.
(iv) Blood transfusion may sornetimes be
indicated in the treatment of anemia of
renal failure.
(a) None of the above staternents is true.
(b) A11 of the above statements are true.
(c) OnIy statements (i) and (ii) are true.
..... (d) Only statement.s (iii) and (iv) are
true.
...Lol-
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L4. Which of the following statements is/are true?
(I) Aluminum hydroxlde is used to lower serum
calcium in patients with chronic renal
failure
(ii) Vitarnin D supplements are useful to treat
the anemia of chronic renal failure.
(iii) Dietary protein should be restricted in
patients with chronic renal failure.
(iv) Potassiun binding resin can cause sodiurn
overload in patients with chronic renal
failure.
(a) None of the above statements is true"
(b) AII of the above statements are true.
(c) Only statements (i) and (ii) are true.
(d) only statements (iii) and (iv) are
true.
420
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15. Which of the following statenents is true?
(a) Adninistration of bicarbonate to a
patient with acute renal failure can
cause hyperkalernia.
(b) Insulin is elininated from the body
through the kidneys.
(c) Calcium caibonate is used in patients
with chronic renal failure as a calcium
supplement.
(d) Dialysis is not an efficient way to
remove excessive body potassium.
16. Which of the followinq statements is true?
(a) Packed ce]Is transfusion is more
suitable than whole blood in patients
with renal failure because there is
less sodium.
(b) Atenolol is the p-blocker of choice in
renal fail-ure because it is excreted in
the liver.
(c) Hypertension can both be a cause and a
consequence of renal failure.
(d) Captopril may be useful to.reverse the
proteinuria of nephrotic syndrome,
...72/-
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L7. Which of the following statements islare true about
treatment of hyperkalenia?
(i) Calciun adninistrat'ion will cause a shift
of potassium frorn ECF to the ICF.
(ii) sodiurn bicarbonate administration
temporarily antagonizes the cardiac and
neuromuscr.llar effects of hyperkalemia.
(iii) Cation-exchange resins bind potassiurn in
exchange for another cation in the blood.
(iv) Dialysis is the treatrnent of choice for
hyperkalemia.
(a) None of the above statements is true.
(b) All of the above statements are true.
(c) Only statements (i) and (ii) are true.
(d) OnIy statements tiii) and (iv) are
true.
422
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1"8. Which of the following st,atenents is/are true in
relation to the nanaltenent of renal failure?
(i) Protein intake should be reduced.
(ii) Both hypotension and hypertension must be
treated pronptly.
(iii) Aluminum hydroxide containing antacids are
used to reduce absorption of phosphate.
(iv) Mild acidosis does not require treatment.
{a) None of the above statements is true.
(b) A11 of the above statenents are true.
(c) Only statements (i) and (ii) are true.
(d) Only statements (iii) and (iv) are
true.
1"9. Which of the f,ollowj"ng statements is/are true about
g I omeru lonephropath i es ?
{i) About 80? of adults with minirnal change
disease responds ts steroid.
(ii) Steroids are the rnainstay in the treatment
of lupus nephritis.
(iii) There is no specific therapy for
poststreptococcal glomerulonephritis.
(iv) In focal glomerulonephritis, the disease
involves some parts of some glomeruli.
423
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(a) None of the above statements is true.
(b) AII of the above statements are true,
(c) Only statements (i) and (ii) are true.
{d) On}y statements (iii) and (iv) are
true.
20. Which of the following statenents is/are true about
nephrotic syndrome?
(i) It is characterized by prot,einuria
(3.Sclday), hypoalbuminemia, hypolipidemia
and edema,
(ii) Aggressive diuretic therapy is usually
indicated to manage the edema.
(iii) Hypercoagulable state can occur.
( iv) Diet,ary prot,ein restriction may be
appropriate for patients with renal
insufficiency.
..... (a) None of the above statenents is true.
(b) All of the above statements are true.
(c) Only statements (i) and (ii) are true.
(d) OnIy statements (iii) and (iv) are
true.
424
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2L. Which of the following statements is/are true?
(FcPs52 )
Renal faj-lure results in phosphate
retentj-on with a reciprocal faII in serum
calcium.
Aluminum from Amphojel can cause
osteornalacia in patients with chronic
renal failure.
Anemia of renal" failure generally does not
require specific treatment.
Digoxin can be removed frorn the body by
hernodialysis.
None of the above statements is true.
A11 of the above statements are true.
Only staternents (i) and (ii) are true.
OnIy statements (iii) and (iv) are
true.
.. 
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( ii)
( iii)
(iv)
(a)
(b)
(c)
(d)
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22. Which of the following statements is true?
(a) Hydrochlorothiazide can cause
hypocalcemia,
(b) Frusemide is effective even at
glomerular filtration rate less than
25 nI/min.
(c) Frusemide reduces glomerular
filtration rate.
(d) Thiazides increase glornerular
filtration rate.
(i) Extracellular fluid compartment consj-sts
of plasma and interstitial fluid.
(ii) Total body water rnakes up 10t of body
weight.
(iii) The major extracellular fluid anion is
. chloride.
(iv) The major intracellular fluid sation Ls
potassium.
...L7/'
23. Which of the following statements is/are true?
rl26
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Only statements (i) and (ii) are true.
only statements (i), (ii) and (iii) are
true.
Staternents (i), (ii), (iiii' and {iv)
are all true.
Only statement (iv) is true.
(a)
(b)
(c)
(d)
24. llhich of the following statenents regarding renar blood
flow is/are true?
(i) Hydrostatic pressure is higher in
glonerular capillaries than in renal vein.
Reduction of renal blood flow is
associated with decreased secretion of
renin
Oncotic pressure of plasma albumin will
retain fluid within the capillary,
Autoregulatory mechanisms maintain tlre
glomerular filtration rate.
( ii)
(iii)
( iv)
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(a) Only statements (I) and (ii) are true.
(b) only statements (i), (ii) and (iii) are
true.
(c) Statements (i), (ii), (iii) and (iv)
are all true.
(d) only statement (iv) is true.
25. Wbich of the following staternents regarding renal blood
flow is/are true?
(i) Glonerular filtration rate (GFR) is
reduced in the elderly.
(ii) 'GFR is measured by collecting a 24-hour
urine specimen.
(iii) Plasma creatinine varies with dietary
protein intake.
{iv) Blood urea depends on lean body mass.
(a) only statements (i) and (ii) are true.
(b) only statements (i), (ii) and (iii) are
true.
(c) Statements (i), (ii), (iii) and (iv)
are all true.
(d) only statement (iv) is true.
...Lel-
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26' which of the forrowing is not a cause of acute renar
failure?
(a) Hemorrhage.
(b) Septicenia.
(c) Anphotericin B.
(d) Mininal-change
glomerulonephritis.
27. whi.ch of the forlowing islare appropriate as an urgent
treatment of hyperkalemia?
(i) Intravenous calcium.
(ii) Glucose and insulin infusion.
(iii) Sodium infusion.
(iv) Infusion of bicarbonate.
(a) only (i) .and (ii) are appropriate.
(b) only (i), (ii) and (iii) are
appropriate.
(.c) (i), {ii), (i-ii} and (iv) are alL
appropriate.
(d) OnIy (iv) is appropriate.
429
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28. Which of the following statenents regarding the
management of renal failure is/are true?
(rcP552 )
(i) The use of loop diuretics should be
considered only after a full fluid
eplacement.
(ii) Protein intake should be restricted,
(iii) Dialysis is indicated if serum potassium
is more than 7.0 rnmol/L.
(iv) Hypocalcemia is treated with t,25-
dihydroxycholeca lci f erol
(a) only (i) and (ii) are appropriate,
(b) only (i), (ii) and (iii) are
appropriate.
(c) (i), (ii), (iii) and (iv) are all
appropriate.
(d) only (iv) is appropriate.
430
...2L/-
2l
)
(FCPss2 )
rNDEX NO:
29. Which of the following statenents regarding chronic
renal failure (CRF) is/are true?
(i) The commonest cause is chronic
glomerulonephritis 
.
(ii) Hypernatremia is commonly due t,o volume
overload.
(ij-i) The use of glibenclarnide is
contraindicated
(iv) The use of aminoglycoside is
contraindicated.
(a) only statements (i) and {ii) are true.
(b) only statements (i), (ii) and (iii) are
true.
(c) Staternents (i), (ii) , (iii) and (iv)
are aII true.
(d) Only sLatement (iv) is true.
431
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30. Which of the following is/are cause(s) of anemia in CRF?
(i) Reduced survival of the red blood cells.
(ii) Gastrointestinal bleeding
tiii) Bone marrohr depression.
' (iv) Edema.
(a) only (i) and (ii) are true.
(b) only (i), (ii) and (iii) are true.
(c) (i), (ii), (iii) and (iv) are all true.
(d) only (iv) is true,
31. Which of the following statenents regarding renal bone
disease is/are true?
(i) It is due to the failure of the kidney to
convert cholecalcj.ferol to L,25 dihydroxy-
cholecalciferol.
(ii) Serum alkaline phosphatase is elevated.
(iii) It can be treated with 25-hydroxy-
cbol"ecalcif erol .
(iv) It causes ricketts in adults.
432
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Only statements (i) and (ii) are true.
only statements (i), (ii) and {iii} are
true.
Statements (i), (ii), (iii) and (iv)
are all true.
Only statement (iv) is true.
(a)
(b)
(c)
(d)
32. Which of
renal failure
the following regarding the therapy of chronic
is/are true?
(i) Hyperphosphatenia is treated with ealcium
carbclnate.
Restricting fluid to 4OO rnl plus the
volume of the previous day urine output
will avoid volume overload.
ttypercalcemia is treated r,,rith Resonium A@
Subcutaneous erythropoeitin is used to
treat anemia.
( ii)
( iii)
( iv)
,433
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(a) Only statenents ti) and (ii) are true.
.,,,. (b) OnIy statements (i), (ii) and (iii) are
true.
,..,. (c) Statements (i), (iii, (iii) and (iv)
are aII true.
(d) Only staternent (iv) j.s true.
33. Which of the following about the management of nephrotic
syndrome is/are true?
(i) SaIt intake should be restricted.
(ii) Water restriction is not required in
stable patients.
(iii) The use of diuretic to reduce edema is
safe.
(iv) Caloric intake should be reduced.
(a) OnIy statenents (i) and (ii) are true.
(b) only statements (i), (ii) and (iii) are
true.
(c) Statements (i), (ii), (ifi) and (iv)
are all true.
(d) Only statement (iv) is true.
...25/-
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34. Which
nephrotic
( FePs52 )
ofof the following is/are complication(s)
syndrome?
(i)
( ii)
CelIulltis.
Thronbosis.
(iii) Hypercholesterolernia.
(iv) Peritonitis.
(a)
(b)
{c)
(d)
Only (i) and (ii) are true.
onLy (i), (ii) and (iii) are true.
(i), (ii), (iii) and (iv) are atl true.
Only (iv) is true.
35. Which of the
respond to both
following conditions islare like1y to
steroid and cytotoxic therapy?
(i)
( ii)
{iii)
( lv)
Minirnal-change nephrotic syndrome.
Wegnerrs granulomatoses.
Henoch Schoelein syndrome.
Focal segmental glomerulosclerosis,
(i) and (ii) only.
(i), (ii) and (iti) only.
A1I (i), (ii), (iii) and (iv).
(iv) on1y.
(e)
(b)
(c)
(d)
...26/-
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36. Which of the foLlowing problems is/are more suggestive
of nephrotic rather than nephritic syndrome?
(i) Henaturia.
(ii) Hypertension.
(iii) oliguria.
(iv) Hypercholesterolemia.
(a) (i) and (ii) onLY.
. . , . . (b) (i) , (ii) and (iii) onIY.
(c) AlI (i), (ii) 
' 
(iii) and (iv).
(d) ( iv) onIY
37. Which of the following staternents regarding symptoms of
renal disease is/are true?
' (i) Renal colic is commonly caused by renal
stone.
(ii) Dysuria neans painful urination.
(iii) Urgency irnplies a sudden. urge to pass
urine.
(iv) Frequency means frequent passage of urine-
a.)rrrl-arr
-r !, v,
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(a) OnIy statements (i) and (ii) are true.
(b) OnIy statenents (i), (ii) and (iii) are
true.
(c) Statements (i), (ii), (iii) and (iv)
are aII true.
(d) OnIy statement (iv) is true.
38. Which of the following statements regarding acute
glomerulonephritis is/are true?
(i) It commonly occurs within ten days of a p-
henolytic streptococcal infection.
(ii) It can lead to renal failure.
(iii) It usually presents as nephrotic synd,rome.
(iv) It is more conmon among adults,
(a) Only statements {i) and (ii} are true.
(b) only statements (i), (ii) and (iii) are
true,
(c) Statements (i), (ii), (iii) and (iv)
are all true.
(d) Only statement (iv) is true.
i'. .
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39. Which of the following statenents regarding the effects
of cyclosporin-amphotericin B interaction is true?
There is enhanced nephrotoxicity.
There is an increase in
hypertrichosis
There is prolonged paralYsis.
There is prolonged rhabdomyolysis'
40. Which of the following statements regarding infections
in renal transplant patients is true?
(a)
(b)
(c)
(d)
(a)
(b)
The rate is generally less than 5*.
Antibiotic prophylaxis is not
reconmended before the procedure to
prevent infections.
The infective agents are limited to
bacteria.
Infection with cytomegalovirus can
lead to graft rejection, loss or
death
(c)
(d)
438
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4L. which of the following cornplicatj-ons is the most conmon
in patients receiving continuos ambulatory peritoneal
dialysis (CAPD) ?
(a) Meningiti-s.
(b) Skin rash.
(c) peritonitis.
(d) Urinary tract infection.
42. which of the following statements regarding hemodialysis
is true?
(a) Solute and fluid are removed through the
patientts peritoneum.
(b) During dialysis, blood is pumped from the
patient through a colurnn of ad.sorbent
material and recirculated back into the
patient.
(c) The duration of dialysis is usually more
than 24 hours.
(d) During dialysis, blood is most cornmonly
purnped through a cylindrical cartridge
dialyser where solutes and fluid.s are
removed by diffusion through a synthetic
membrane
. . .30/-
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43. Which of the drugs is not appreciably removed by
hemodialysis?
(a) Digoxin.
(b) Acyclovir.
(c) Gentamicin.
(d) Aspirin.
44. Which of the following is the most efficiently removed
by hemodialysis?
(a) Acyclovir.
(b) Digoxin.
(c) Vancomycin.
(d) Ketooonazole.
45. Which of the following staternents is true?
(a) Digoxin reduces GFR in patients with
chronic renal failure.
(b) Nephrotoxicity can occur in patients
with hepato-rena} syndrome given
neomycin oraIly.
(c) Frusemide can still exert a diuretic
effect even at a GFR of zerr:.
(d) The dose of thiazide needs to be
reduced in patients with end-stage
renal di.sease.
440
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46. Which of the following statements is true?
(a) Cellular debris causes an obstruction
in the renal tubules of patients who
suffers an acute tubular necrosis.
(b) Mannitol is contraindicated in acute
renal failure.
(c) Potassium supplenent is required by
. all patients given diuretics.
(d) Methyldopa is contraindicated in acute
renal failure.
47, Which of the following statements is true?
(a) In prerenal azotemia urinary sodium is
l-ow.
(b) Low plasma osmot,ic pressure causes
ederna in patients w.ith nephrot,ic
syndrome.
(ci The production of clotting factors is
reduced in patients with nephrotic
syndrome.
(d) High dose frusemide should not be used
n patients with prerenal azotemia.
...32/-
:. .,
t 
.::aAlrrt
32
(rcPs52 )
INDEX NO:
Questions {8-50 refers to the follorin(I cases
A 34 year-oId ldalay man was adnitted to the accident and
emergency unit after sustaining a crush injury to the
abdomen in a motor-vehicle accj-dent. His blood pressure was
found to be 8O/? mm Hg, pulse lOO/rninute and temperature.
36oC. A snall volune of blood-stained urine was obtained
upon catheterization
48. Which of the following is least appropriate for the
above patient?
(a) Adninistration of high dose frusemide
to induce urine flow.
(b). Administration of crystalloid to
expand plasma volume.
(c) Transfusion of blood.
(d) Adrninistration of dopamine after fluid
replacement.
442
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49. which of the following st,aternents is/are true about the
possible renal injury in the patient?
(i) The patient rnay suffer from prerenal azotemia.
(ii) The patient may suffer from acute tubular
necrosis.
(iii) Correction of hypotension is a most important
measure to prevent further renal damage.
(iv) The renal failure is likely to be reversible.
(a) None of the above statements is true.
{b) AIl of the above statements are true.
(c) only statements (i) and (ii) are true.
(d) OnIy statements (iii) and (iv) are
true.
I
50. Which of the following parameters are likely to be
abnormal in the above patient?
(i) Blood urea.
(ii) Serum potassium.
(iii) Total white cell count.
(iv) Plate1et count.
...34/-
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(a) None of the parameters is likely to be
abnormal,
(b) AI1 of the pararneters are likely to be
abnormal.
(c) OnIy parameters (i) and (ii) are likely
to be abnorrnal.
(d) Only parameters (iii) and (iv) are
likely to be abnormal"
444
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sEcTroN (B)
1' RM is an eighteen year-oId Maray female adnitted to HUSM
for the worsening of body swerling. Tr,*o years prior to this
admissj.on, RM was diagnosed as having systemic lupus
erythematosus with a suspicion of renal involvement, and
three months prior to admission, she received prednisolone
60 mg daily PO and Naproxen 280 ng BD pO.
On examination, RM'was noted to be pale and lethargic.
Edema qas noted in the face and ankles. Brood pressure
Lgo/ 110 mm Hg, pulse T2lninute and respiration 2olrninute.
Lungs hrere clear and JVp was not elevated.
Initial laboratory findings were as follows:
Serum sodium L4Z urnol/L
WBc 13000/mrn3
Serum Potassium 4,5 umol/L
Hernoglobin 7 .L g/L
Blood Urea 11.0 umol/L
Hematocrit 22.4*
Serum Creatinine LL7 umol/L
P1atelet ;:6/ **3
Serum Protein i'? g/L
Serum Albunin 22 g/L
Serum Globu1in LS q/L
. ...36 / -
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Based on history, physical and laboratory findings, the
following diagnoses r'ilere entered.
1. Systemic lupus erYthematosus.
2. Nephrotic syndrome.
3. Hypertension
4. Lupus nephritis.
5. Anemia.
A. Based on the above diagnoses, explain the following
abnormalities found in the patient:
a) ankle and facial edema.
b) lethargy,
c) hypertension
d) elevated serum creatinine.
(5 Marks)
.. .37 /-
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a
After a review by the nedical consultant, the forlowing drug
therapy was instituted in RM:
Nifedipine 30 mg TDS pO
Frusemide 40 ng BD pO
Spironolactone 50 ng BD pO
Atenolo1 5O mg BD pO
Prednisolone 50 mg eD pO
Ferrous sulphate 200 ng eD pO
Fo1ic acid 5 rng eD pO
B. Describe your objectives for the management of RM.
(5 Marks)
...38/-
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c. Discuss the above drug therapy prescribed for RII in
relations to his underlying conditions of lupus nephritis,
hypertension and edema'
(10 Marks)
A renal biopsy was performed on RM and the followingr
diagnosis was made:
Systemic lupus erythematosus with lupus.nephritis' 
- 
Class
Iv with active disease.
A plan was made to treat the patient with cyclophosphamide
z5o ngrn 2 w
. . .391-
448
39
3
(FCP552 )
D. Di"scuss the role of cyclophosphanide in the above
patient,.
(5 Marks)
2- Bryan and stone (Ann. rntern Med. LgTs:82:1g9) proposed
an equation to estimate the totar daily dose of penicirlin
for patients with an estimated creatinine crearance of ress
than 40 mI/rnin. His formula is as follows:
fn
Dose (Mu/day) = 32+ryI
(a) what dose of penicirlin G shourd be used for treating
meningococcal rneningitis in Mr. AB (Age s7, weight 95 kg,
serum creatinine 3g? prmol/L) ?
(5 Marks)
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{b) Comment
equat.ion in
on the clinical
individualizing
usefulness of the above
penicillin dose.
(c) Discuss possible adverse effects
azathioprine. adrninistration in renal
(7 Marks)
associated with
transplant patients.
(d) Discuss the factors that
drugs.
450
(5 Marks)
i-nfluence the dialyzabilitY of
(7 Marks)
...4L/-
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- Norual Laboratory Values
1. Ammonia 80-110 rncg/dl or 47-65 urnol/L
2. Amilase 4-ZS IU/rnl
3. Billirubin
Direct O-0.2 mg/gl O-3 umol/LIndirect O.2-0. S ng/d1 30-1"4 umolllTotal 0.2-L rngldl 30-17 umol/L
4. Coz 20-30 nEq/L 24-30 mMoI/L
5. pCOZ 35-45 rnurHg
6. CI 100-106 nEq/L 100-106 mMol/L
7. cpk so-170 U/L
8. Creatj-nine (SCr) o. 6-1. 5 rng/dl 60-130 umol/L
9. Randorn blood sugar ZO-l_10 rng/dl 3-LO urnol/L
10. Iron 50-150 ncg/dI 9.0-26.9 umol/L
11. Lactic 7O-ZLO IU/L
dehydrogenase
L2" Magnessium L.|-Z.O nEq/L O.B-1.3 mMoI/L
1-3. pAZ 75-100 nmHg
L4. pH ?,is-7.4s
15. Acid phosphatase
Male 0 . 13-0. 63 IU/m} 36-L7 6 nmol r-111,Female O. 10l"-0.65 IU/nI Z .B-LS6 nmol s-./L
16. Alka1ine 3g-Lt7 IV/Lphosphatase
L7 . Phosphorous 3,0-4.5 rng/dl j-. O-1.5 rnMoI/L
18. Potassium (K+) 3 . 5-5. O rnEq/L 3 .5-5. O mMol/L
ls. Calciun (caz+) 8.s-10.5 mg/dl z.t-2.5 mMoI/L
20. Sodiun (Na+) 135-145 nEq/L 135-145 nMol/L
21. Bicarbonate (Hco3-) 24-39 nEq/L z4-zg rnMol/L
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22. ProteinTota1 6.0-8.5 g/dl 50-85 g/LAlbunin 3.s-5.0 g/dl 35-5A g/LGlobulin 2.3-3.5 g/dl 23-35 glLTransferrin 2OO-4OO ng/dl 2.O-9.O glL
23. Transaminase O-40 TVIL 0-0.32 umol =-L/f(sGoT)
24. BUN 8-25 mg/dl 2.9-8.9 nMoI/L
25. Uric Acid 3-? rng/d1 0.18-0.42 nMol/L
26. B1ood Pictures
Red blood cell (RBC) 
_e. *3Male 4.8-6.4 x 1ollm...^Female 4.2'5.4 x lOo/nmr
Whi.te blood cetl (wBc) 4 
" 
o-11.0 x Lorlmrnr
P 60-752L 20-408M 4-8tB 0-18
E 1-38
Platelate {PIt} 200-400 x :.O37rnm3
27. ESR . I{a}e 0-10 nrn/jan (Wintrobe)Female 0-15 nmljarn (Wintrobe)
28. HematocritMaIe 45-52*Female 37-48*
29. Hemoglobine {Hgb)Male 13-18 gldlFemale L2-L6 g/dl
30. Prothrombin tine 75-1008 nilai asas
( PT)
31. APTT 25-37 saat
32 . Creatinine L05-150 rnllninl 1.73 m2
Clearance(crcl)
33. TfA 3.0-7. s mcg/dl
34. RT3U 25-358
35. FTr L.3-4.2
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NORMAL HEMODYNA}'IC VALUES AND DERIVED INDICES
Normal Value Units
BP s/D/M
co
RAP
PAP S/D/M
PCWP
cr
sv
svI
PVR
TPVR
LVSWT
Blood Pressure
Systol icl Diastolic/Mean
Cardiac Output
Right Atrial Pressure(Mean)
Pulmonary Artery pressure
Systol ic / Diasto I ic /Mean
Pulmonary Capillary WedgePressure (nean)
Cardiac fndex
LzO / 8A /e3
4-6
2-6
25/L2/L6
5-12
2 .5-3.5
nm Hg
Liters/nin.
nm Hg
mm Hg
mm Hg
Liters/rn inlmz
Cf=
Body Surface Area
Stroke Vol-ume
SV=
Heat Rate
Stroke Volurne Index
svI
SVI=
Body Surf,ace Area
Pulmonary Vascular
Resistance
MPAP - PCWP
50 80 nlr/beat
30 50 nl/beat/n2
dynes. sec. cm-=
900-1_4 00 dynes. sec. cm-D
gm-n7n27beat
x80
co
Total Peripberal Vascular
Resistance
I'!BP - RAP
TPVR= x80
Left Ventricular Stroke
Work trndex 3S-BOLvswl = (MBP-PCWP) (svl) (.0136)
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